Notices to Readers
Report on National HIV Seroprevalence Surveys
CDC collaborates with state and local health departments, other
federal agencies, blood collection agencies, and medical research
institutions to conduct human immunodeficiency virus (HIV)
seroprevalence surveys in a variety of sentinel populations.
Together these surveys constitute a serosurveillance network to
monitor the prevalence of HIV infection in the United States.
This "family" of surveys includes studies among patients at
sexually transmitted disease clinics, drug-treatment centers,
women's health clinics, and tuberculosis clinics in 44 cities;
patients at sentinel hospitals in 30 cities and in a network of
ambulatory-care practices; childbearing women in 44 states, the
District of Columbia, and Puerto Rico; and blood donors,
applicants for military service, and Job Corps entrants (Figure
1).
Single copies of the publication, National HIV Seroprevalence
Surveys--Summary of Results: Data from Serosurveillance
Activities through 1989 (1), are available free of charge from
the National AIDS Information Clearinghouse, P.O. Box 6003,
Rockville, MD 20850; telephone (800) 458-5231.
Reference
CDC. National HIV seroprevalence surveys--summary of results:
data from serosurveillance activities through 1989. Atlanta: US
Department of Health and Human Services, Public Health Service,
1990; DHHS publication no. (CDC)HIV/CID/9-90/006.
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to [email protected].
